Showing results (341-350 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 9, 2013
Agonistic anti-CD40 antibody therapy is effective against postoperative cancer recurrence and metastasis in a murine tumor modelAndrea Khong, Matthew D Brown, Justin B Vivian, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 8, 2015
Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic CancersTristen S Park, Eric M Groh, Krishna Patel, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 9, 2015
Treatment of in-transit melanoma with intralesional bacillus Calmette-Guérin (BCG) and topical imiquimod 5% cream: a report of 3 casesNour Kibbi, Stephan Ariyan, Mark Faries, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 4, 2016
A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor CellsAdnan Jaigirdar, Steven A Rosenberg, Maria ParkhurstJournal of Immunotherapy (Hagerstown, Md. : 1997)|March 4, 2016
An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T CellsKenta Kondo, Fumihiro Fujiki, Hiroko Nakajima, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 2, 2015
Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief CommunicationTracy R Daniels-Wells, Daniel P Widney, Lai Sum Leoh, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 2, 2015
A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing TumorsCatherine Gérard, Nathalie Baudson, Thierry Ory, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 12, 2015
Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of CancerMunjal Pandya, Kellee Britt, Brad Hoffman, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 22, 2014
Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanomaMatthew M K Chan, Richard F Kefford, Matteo Carlino, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2020
Prognostic Significance of Tumor-infiltrating Lymphocytes on Survival Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-AnalysisHarold N C Tan, Lance I G Catedral, Michael D San JuanPageof 175